Esperion Therapeutics Current Ratio 2011-2026 | ESPR

Annual Current Ratio Esperion Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.469	0.311	0.434	0.66	3.68	3.2	2.22	6.15	13.7	38.1	19.4	14.4	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
38.1	0.311	8.57

Quarterly Current Ratio Esperion Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
0.45	0.44	0.43	0.46	0.51	0.56	0.35	0.39	0.43	0.43	0.52	-	0.58	0.66	0.38	0.48	0.51	0.79	0.79	0.79	0.79	1.1	1.1	1.1	1.1	2.23	2.23	2.23	2.23	8.38	8.38	8.38	8.38	14.8	14.8	14.8	14.8	35.6	35.6	35.6	35.6	14.7	14.7	14.7	14.7	18.6	18.6	18.6	18.6	0.3	0.3	0.3	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
35.6	0.3	7.71

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Alector ALEC	1.12	$ 2.19	-9.77 %	$ 226 M	USA
Acer Therapeutics ACER	0.41	-	2.71 %	$ 14 M	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Cabaletta Bio CABA	14.5	$ 3.34	0.45 %	$ 3.9 M	USA
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	1.81	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
Codexis CDXS	1.82	$ 1.02	1.49 %	$ 74.9 M	USA
AbCellera Biologics ABCL	3.48	$ 3.74	3.6 %	$ 1.12 B	Canada
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
Cerus Corporation CERS	1.4	$ 2.6	1.37 %	$ 480 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
Cellectis S.A. CLLS	1.52	$ 3.87	-0.39 %	$ 116 M	France
ARCA biopharma ABIO	28.7	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	13.4	-	4.01 %	$ 150 M	Canada
CNS Pharmaceuticals CNSP	3.45	$ 3.23	2.22 %	$ 1.23 M	USA
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
AIkido Pharma AIKI	6.48	-	1.93 %	$ 17.4 M	USA
Collegium Pharmaceutical COLL	1.22	$ 41.75	0.19 %	$ 1.32 B	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	2.39	-	-0.23 %	$ 916 M	USA
Corcept Therapeutics Incorporated CORT	4.43	$ 36.14	1.23 %	$ 3.75 B	USA
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA
Amarin Corporation plc AMRN	2.97	$ 13.98	1.27 %	$ 5.7 B	Irlanda
Aileron Therapeutics ALRN	7.98	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	22.6	-	4.14 %	$ 49.1 M	USA
Catalyst Pharmaceuticals CPRX	7.37	$ 23.77	2.99 %	$ 2.91 B	USA
Alpine Immune Sciences ALPN	2.67	-	-	$ 2.17 B	USA
Corbus Pharmaceuticals Holdings CRBP	0.804	$ 8.41	-1.87 %	$ 36.4 M	USA
Cardiff Oncology CRDF	3.75	$ 1.94	0.01 %	$ 130 M	USA
Curis CRIS	0.873	$ 1.1	-3.51 %	$ 6.94 M	USA
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
CorMedix CRMD	6.89	$ 7.16	0.42 %	$ 364 M	USA
Ampio Pharmaceuticals AMPE	2.41	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	2.31	-	-	$ 10.1 M	USA
Champions Oncology CSBR	1.13	$ 6.14	3.89 %	$ 83.9 M	USA
Aravive ARAV	1.21	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	0.69	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Citius Pharmaceuticals CTXR	2.74	$ 0.72	-2.34 %	$ 4.84 M	USA
Athira Pharma ATHA	4.22	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	0.378	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	8.82	$ 4.21	-2.32 %	$ 299 M	USA
CEL-SCI Corporation CVM	1.91	$ 3.88	-8.92 %	$ 247 M	USA